Supporting patients left in limbo by DTC BRCA genetic testing

June 7, 2018

When the FDA authorized the first direct-to-consumer (DTC) BRCA test in March, they did so with the caveat that any positive test result requires confirmation and genetic counseling before it can be used to inform medical treatment. Historically, insurance will only cover BRCA testing if a person has a significant personal or family history... Read More

March 30, 2018

When considering a genetic test to learn your risk for hereditary cancer, it’s important to consider a few factors when choosing the right test for you. Here are three essential questions to ask when weighing the choices: Is the test... Read More